Pursuant to Regulation 33 of the SEBI (LODR)-submitted herewith the Un-audited Standalone and Consolidated Financial Results along with the Limited Review Report of the Statutory Auditors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Narmada Gelatines posted strong Q2 FY26 results, with standalone revenue from operations rising to ₹5,121 lakhs (up 6.9% from ₹4,791 lakhs in Q2 FY25) and profit after tax nearly doubling to ₹648 lakhs (vs ₹383 lakhs). For the half year ended September 2025, standalone revenue grew to ₹9,698 lakhs and PAT jumped to ₹1,146 lakhs (vs ₹783 lakhs), translating to an EPS of ₹18.94. Consolidated H1 FY26 PAT stood at ₹1,287 lakhs, aided by a ₹191 lakh share of profits from associate India Gelatine and Chemicals. Profit before tax margin expanded sharply from ~10.6% to ~17.5% year-on-year on the standalone base, driven by lower finance costs and stable input expenses. Operating cash flow remained healthy at ₹983 lakhs for H1, though cash and cash equivalents dipped to ₹10 lakhs as the company paid ₹603 lakhs in dividends and continued capex (capital work-in-progress of ₹678 lakhs). Statutory auditors Lodha & Co LLP issued an unmodified limited review report with no qualifications.
A robust ~69% YoY jump in standalone quarterly PAT and meaningful margin expansion signal strong operational performance, likely positive for sentiment. Low leverage and steady operating cash flow support continued dividend payouts and ongoing capex, though cash levels remain thin.